These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30725510)

  • 1. Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study.
    Vadivel K; Schreuder HA; Liesum A; Schmidt AE; Goldsmith G; Bajaj SP
    J Thromb Haemost; 2019 Apr; 17(4):574-584. PubMed ID: 30725510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
    Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
    J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.
    Johnson DJ; Langdown J; Huntington JA
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):645-50. PubMed ID: 20080729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.
    Yang L; Rezaie AR
    J Biol Chem; 2013 May; 288(18):12692-8. PubMed ID: 23530052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets.
    Yang X; Chang YJ; Lin SW; Walsh PN
    J Biol Chem; 2004 Nov; 279(45):46400-5. PubMed ID: 15328360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
    Brandstetter H; Bauer M; Huber R; Lollar P; Bode W
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9796-800. PubMed ID: 7568220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the heparin binding exosite of factor IXa.
    Yang L; Manithody C; Rezaie AR
    J Biol Chem; 2002 Dec; 277(52):50756-60. PubMed ID: 12397068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex.
    Wilkinson FH; Ahmad SS; Walsh PN
    J Biol Chem; 2002 Feb; 277(8):5734-41. PubMed ID: 11714704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.
    Qureshi SH; Yang L; Rezaie AR
    Thromb Haemost; 2012 Dec; 108(6):1154-64. PubMed ID: 23014580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.
    Yang L; Manithody C; Qureshi SH; Rezaie AR
    J Biol Chem; 2010 Sep; 285(37):28488-95. PubMed ID: 20628058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding.
    Hopfner KP; Lang A; Karcher A; Sichler K; Kopetzki E; Brandstetter H; Huber R; Bode W; Engh RA
    Structure; 1999 Aug; 7(8):989-96. PubMed ID: 10467148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa.
    Neuenschwander PF
    Biochemistry; 2004 Mar; 43(10):2978-86. PubMed ID: 15005634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.
    Venkateswarlu D
    Biochem Biophys Res Commun; 2014 Sep; 452(3):408-14. PubMed ID: 25157807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.
    Plautz WE; Sekhar Pilli VS; Cooley BC; Chattopadhyay R; Westmark PR; Getz T; Paul D; Bergmeier W; Sheehan JP; Majumder R
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):816-828. PubMed ID: 29419409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of human factor VIIa-soluble tissue factor with calcium, magnesium and rubidium.
    Vadivel K; Schmidt AE; Cascio D; Padmanabhan K; Krishnaswamy S; Brandstetter H; Bajaj SP
    Acta Crystallogr D Struct Biol; 2021 Jun; 77(Pt 6):809-819. PubMed ID: 34076594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Structure Based Study of Selective Inhibition of Factor IXa over Factor Xa.
    Kundu S; Wu S
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII A3 domain residues 1793-1795 represent a factor IXa-interactive site in the tenase complex.
    Takeyama M; Furukawa S; Sasai K; Horiuchi K; Nogami K
    Biochim Biophys Acta Gen Subj; 2023 Aug; 1867(8):130381. PubMed ID: 37207906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
    Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
    J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships in factor IX and factor IXa.
    Schmidt AE; Bajaj SP
    Trends Cardiovasc Med; 2003 Jan; 13(1):39-45. PubMed ID: 12554099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
    Westmark PR; Tanratana P; Sheehan JP
    J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.